(Q42910107)

11 November 2017

title

Secondary prevention of stroke: can we do better than aspirin? (English)

1 reference

11 November 2017

1 reference

2

Deepak L Bhatt

1 reference

11 November 2017

Dharam J Kumbhani

1

1 reference

11 November 2017

publication date

15 September 2010

1 reference

11 November 2017

1 reference

11 November 2017

volume

9

1 reference

11 November 2017

issue

10

1 reference

11 November 2017

page(s)

942-943

1 reference

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

Clinical aspects of platelet inhibitors and thrombus formation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

Intensifying platelet inhibition--navigating between Scylla and Charybdis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970217-9

7 January 2021

10.1016/S1474-4422(10)70217-9

Identifiers

DOI

1 reference

11 November 2017

1 reference